References
- 1. Farrell PM. The prevalence of cystic fibrosis in the European Union. J Cyst Fibros. 2008;7(5):450-3. DOI: 10.1016/j.jcf.2008.03.00710.1016/j.jcf.2008.03.00718442953
- 2. Wang Y, Wrennall JA, Cai Z, Li H, Sheppard DN. Understanding how cystic fibrosis mutations disrupt CFTR function: from single molecules to animal models. Int J Biochem Cell Biol. 2014 Jul;52:47-57. DOI: 10.1016/j. biocel.2014.04.001
- 3. Ong T, Marshall SG, Karczeski BA, et al. Cystic Fibrosis and Congenital Absence of the Vas Deferens. 2001 Mar 26 [Updated 2017 Feb 2]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1250/
- 4. Castellani C, Macek M, Cassiman JJ, Duff A, Massie J, ten Kate LP, et al. Benchmarks for Cystic Fibrosis carrier screening: A European consensus document. J Cyst Fibros [Internet]. 2010;9(3):165-78. DOI: 10.1016/j. jcf.2010.02.005
- 5. Ioannou L, McClaren B, Massie J, Lewis S, Metcalfe S, Forrest L, et al. Population-based carrier screening for cystic fibrosis: a systematic review of 23 years of research. Genet Med. 2014 Mar;16(3):207-16. DOI: 10.1038/gim.2013.12510.1038/gim.2013.12524030436
- 6. Frenţescu L, Brownsell E, Hinks J, Malone G, Shaw H, Budişan L, et al. The study of cystic fibrosis trans-membrane conductance regulator gene mutations in a group of patients from Romania. J Cyst Fibros. 2008;7(5):423-8. DOI: 10.1016/j.jcf.2008.03.00410.1016/j.jcf.2008.03.00418467194
- 7. Dobre M, Chesaru B, Romila A, Tutunaru D, Gurău G. Cystic fibrosis in Romanian children [Internet]. 2015 [cited 2020 Apr 3]. Available from: https://www.researchgate.net/publication/279202066_Cystic_fibrosis_in_Romanian_children.
- 8. Apostol P, Cimponeriu D, Radu I, Gavrila L. The analysis of some CFTR gene mutations in a small group of cf patients from southern part of Romania. Analele Univ din Oradea Fasc Biol [Internet]. 2009;TOM XVI(1):8-11.
- 9. De Vries HG, Collée JM, De Walle HEK, Van Veldhuizen MHR, Smit Sibinga CT, Scheffer H, et al. Prevalence of ΔF508 cystic fibrosis carriers in The Netherlands: Logistic regression on sex, age, region of residence and number of offspring. Hum Genet. 1996;99(1):74-9. DOI: 10.1007/s00439005031410.1007/s0043900503149003498
- 10. Norman R, van Gool K, Hall J, Delatycki M, Massie J. Cost-effectiveness of carrier screening for cystic fibrosis in Australia. J Cyst Fibros [Internet]. 2012 Jul [cited 2020 Dec 14];11(4):281-7. DOI: 10.1016/j. jcf.2012.02.007